Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3549

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3549 5)

Pdp (68071 3549 5)
Car Pharmaceuticals is a company that sells a medication called Sildenafil 100mg. The lot number for this medication is 060000, and the NDC number is 68071-3549-05. The medication is manufactured by MFR with the NDC number 27241-069-10, and the expiration date is not available. The serial number for this medication is 0000000002. Another medication with the same name, Sildenafil 100mg, is also available. The lot number for this medication is 00000, and the NDC number is 68071-3549-05. The medication is also manufactured by MFR with the NDC number 27241-069-10, and the expiration date is not available. The serial number for this medication is 0000000002. The medication comes with a warning to call a doctor for medical advice about side effects, and side effects can be reported to the FDA at 1-800-FDA-1088. It is important to keep the medication out of the reach of children and store it at a controlled temperature of 68-77°F.*
FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
Figure 5 shows the average plasma concentrations of Sildenafil in a group of healthy male volunteers. The graph represents the levels of the drug in the bloodstream over a certain period of time. This information is likely part of a scientific study or clinical trial evaluating the pharmacokinetics of Sildenafil in healthy individuals.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
Percentage patients reporting improvement: 4%, 63%, 24%, and 2%. The text also mentions the names of two types of tablets: Placebo Sidenail Sideral and Sitdari Tablets.*
FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.